Delivery of miRNA-126 through folic acid-targeted biocompatible polymeric nanoparticles for effective lung cancer therapy
Journal of Bioactive and Compatible Polymers · 2022-05 · 37 (3) · 168-188
DOI: 10.1177/08839115221095152 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Bioactive and Compatible Polymers, online erschienen am 12.05.2022. Verfasst von Forough N Golafzani und 5 weiteren Autor:innen. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Objective
Nanoparticle-based drug delivery systems (DDSs) have been playing a considerable role in the eradication of cancer. In this experimental study, we designed and synthesized folic acid (FA)-decorated chitosan (CS) nanocarrier for targeted delivery of miR-126 (as a therapeutic agent) to lung cancer A549 cells. Materials and methods: Therefore, the FA-CS-miR-126 nano-complex was perfectly developed and characterized by various analytical devices such as Fourier transform infrared (FT-IR) and dynamic light scattering (DLS) spectroscopies and as well as transmission electron microscopy (TEM). The size was determined lower than 100 nm for synthetics. Then, a gel retardation assay was performed to investigate the entrapment efficiency of nano-complex. Afterward, the sort of in vitro assays was implemented on A549 (FA receptor-positive lung cancer cell line) and MRC5 (normal human diploid cell line) to evaluate the therapeutic efficiency of FA-CS-miR-126.
Results
As the cell viability (40.7 ± 2.98% cell viability after 72 h treatment with 500 nM), migration assay (weaker migration after 24 h and 48 h), apoptotic and autophagy genes expression level (Caspse9: sixfolds; BAX: 17 folds; ATG5: fourfolds; and BECLIN1: threefolds more than the control group), the reduced expression level of EGF-L7, as a target gene for miR-126 was evaluated by Real-Time PCR too, then, cell cycle arrest (8.66% of cells in sub-G1 phase), and cell apoptosis assay (21.0% of cancer cell in late apoptosis phase) were scrutinized.
Conclusion
These results are remarkably approved the biocompatible and efficient performance of FA-CS-miR-126 as a promising DDS.
Zitieren
APA
Golafzani, F. N., Vaziri, A. Z., Javanmardi, M., Seyfan, F., Yazdanifar, M., & Khaleghi, S. (2022). Delivery of miRNA-126 through folic acid-targeted biocompatible polymeric nanoparticles for effective lung cancer therapy. Journal of Bioactive and Compatible Polymers, 37(3), 168-188. https://doi.org/10.1177/08839115221095152
Vancouver
Golafzani FN, Vaziri AZ, Javanmardi M, Seyfan F, Yazdanifar M, Khaleghi S. Delivery of miRNA-126 through folic acid-targeted biocompatible polymeric nanoparticles for effective lung cancer therapy. Journal of Bioactive and Compatible Polymers. 2022;37(3):168-188. doi:10.1177/08839115221095152
BibTeX
@article{Golafzani2022,
author = {Golafzani, Forough N and Vaziri, Ali Z and Javanmardi, Masoud and Seyfan, Fatemeh and Yazdanifar, Mahboubeh and Khaleghi, Sepideh},
title = {Delivery of miRNA-126 through folic acid-targeted biocompatible polymeric nanoparticles for effective lung cancer therapy},
journal = {Journal of Bioactive and Compatible Polymers},
year = {2022},
volume = {37},
number = {3},
pages = {168--188},
doi = {10.1177/08839115221095152}
}
EUVIMED